Back

Elevated HDL-C is associated with adverse cardiovascular outcomes

25 August 2018 (09:18 - 09:36)
Organised by:
Congress Presentation Part of: HDL cholesterol - A moving target Lipids, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Marc Allard-Ratick

Emory University Hospital, Atlanta (United States of America)

4 More presentations in this session

Presentation thumbnail
Mechanistic insights into HDL cholesterol - Current insights.
Professor A. Tybjaerg-Hansen (Copenhagen, DK)
Slides Video
Presentation thumbnail
Serum modified high density lipoprotein levels assessed by a novel assay was associated with coronary artery calcification in an apparently healthy population
Professor T. Okamura (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk . A Meta-analysis.
Doctor L. Lobo (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Next steps in addressing HDL cholesterol clinical practice.
Professor A. Catapano (Milan, IT)

Access the full session

Session thumbnail
HDL cholesterol - A moving target

The Event

Event poster

ESC Congress 2018

25 August 2018 09:18 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources